Johns Hopkins logo

Health Newsfeed

TREATING ERECTILE DYSFUNCTION

LOTS OF TESTING ISN’T NECESSARY WHEN IT COMES TO TREATING ERECTILE DYSFUNCTION, ELIZABETH TRACEY REPORTS

Drugs like sildenafil, marketed as Viagra, fall into a category of medications known as PDE5 inhibitors.  Now the American College of Physicians has looked at a large number of trials related to use of these medications and developed guidelines.  Ballantine Carter, a urologist at Johns Hopkins, describes the recommendations.

CARTER:  The American College of Physicians has recommended that men who have erectile dysfunction be treated with PD5 inhibitors.  They base that on 130 randomized controlled trials.  I think the main message is that the primary care physician doesn’t necessarily need to make a urological referral, doesn’t necessarily need to measure hormone levels in a patient because the drugs are so well tolerated that a trial of PD5 inhibitors is a rational approach in someone who presents with erectile dysfunction.  :30 

Carter says that as with any medication, risks and benefits must be weighed, especially in light of other medications men may be taking, but that primary care doctors are able to make these determinations.  At Johns Hopkins, I’m Elizabeth Tracey.  .



Search Health NewsFeed

-----------------------------------------
Health NewsFeed Home | Hopkins Medicine Home